✦ LIBER ✦
Effect of Prophylactic Treatment with Intravesical Epirubicin on Recurrence of Superficial Bladder Cancer—The 6th Trial of the Japanese Urological Cancer Research Group (JUCRG):: A Randomized Trial of Intravesical Epirubicin at Dose of 20 mg/40 ml, 30 mg/40 ml, 40 mg/40 ml
✍ Scribed by Masao Kuroda; Tadao Niijima; Toshihiko Kotake; Hideyuki Akaza; Shiro Hinotsu
- Book ID
- 113608596
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 130 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0302-2838
No coin nor oath required. For personal study only.